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In this study, electrospray ionization mass spectrometry (ESI-MS) was used to investigate the
binding interactions of ten flavonoid aglycones and ten flavonoid glycosides with DNA
duplexes. Relative binding affinities of the flavonoids toward DNA duplexes were estimated
based on the fraction of bound DNA. The results revealed that the 4 =-OH group of flavonoid
aglycones was essential for their DNA-binding properties. Flavonoid glycosides with sugar
chain linked on ring A or ring B showed enhanced binding toward the duplexes over their
aglycone counterparts, whereas glycosylation of the flavonol quercetin on ring C exhibited a
less pronounced effect. The aglycone skeletons and other hydroxyl substitutions on the
aglycone also have an effect on the fractions of bound DNA. Upon collision-induced
dissociation, the complexes containing flavonoid aglycones underwent the predominant
ejection of a neutral ligand molecule, suggesting an intercalative DNA-binding mode.
However, for complexes containing flavonoid glycosides, the loss of nucleobase increased to
different extents, indicating a stronger binding or different binding mode. The results may
provide not only a deeper insight into the DNA-binding properties of flavonoids but also a
useful guideline for the design of efficient DNA-binding agents for chemotherapy. (J Am Soc
Mass Spectrom 2008, 19, 914–922) © 2008 American Society for Mass SpectrometrySmall molecules binding to nucleic acid structuresare of great interest in modern medicine becausethey constitute a significant portion of the antican-
cer drugs [1]. These drugs may bind to certain DNA
sequences, prevent the specific recognition of these
sequences with their trans-acting factors, and interfere
with the replication or transcription of certain genes,
and thus exert their pharmacological activities [2].
Among the various organic molecules, natural products
have attracted considerable interest given that many
clinical anticancer drugs are natural products (or their
derivatives) and most of them exert their effects by
acting on DNA [1]. In this context, studies of the
binding of natural products with DNA are helpful for
better understanding the molecular basis of their bioac-
tivities as well as providing useful guidance for further
design of more efficient anticancer drugs [1, 3–7].
As an important class of natural products, flavonoids
have received considerable attention because of their
health benefits and chemopreventive properties [8].
Flavonoids consist of a diverse group of compounds
derived from 2-phenolchromotome and can be catego-
rized into several subgroups according to the structure
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doi:10.1016/j.jasms.2008.04.018of the C-ring, such as flavone, flavonol, flavanone,
isoflavone, and flavan-3-ol (Table 1). Flavonoid agly-
cones and their modified forms are widely found in the
roots, stalks, and fruits of many natural plants and act
as the major functional components in many herb
medicines [8, 9]. Many studies have demonstrated that
flavonoids possess a wide range of biological activi-
ties, such as anticancer, antiviral, antibacterial, anti-
oxidants, and anti-inflammatory effects [8]. These
biological activities are considered to be related to
their interaction with several enzymes in the human
body as well as their notable antioxidant activity [8,
10]. Meanwhile, the binding of flavonoids to nucleic
acid structures has also been recognized as one
important mechanism of their actions [11–19].
The noncovalent interactions between flavonoids
and DNA have been elucidated using several solu-
tion-phase techniques including absorption [20, 21],
fluorescence [21], linear dichroism [22], and nuclear
magnetic resonance [23] spectroscopies, as well as
electrochemical [24] and surface plasmon resonance
[25] techniques. However, these methods are labor-
intensive or require large quantities of materials.
Electrospray ionization mass spectrometry (ESI-MS)
has proven to be a powerful tool for examining the
drug/DNA complexes because the intact complexes
can survive the gentle ionization process and be
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low sample consumption and fast analysis time also
render ESI-MS suitable for high-throughput screen-
ing [27]. To date, many well-characterized drug/
DNA complexes have been extensively studied by
ESI-MS [28 – 44]. However, the application of ESI-MS
to characterize the flavonoid/DNA complexes has
been involved only in a recent work for detection of
the daidzin/G-quadruplex complex [45].
Table 1. Structures of the flavonoids investigated in this study
Structure Name
flavone
Baicalein
Apigenin
Luteolin
Baicalin
Vitexin
5,6,
5,7,
5,7,
Baic
Api
flavonol
Quercetin
Quercetrin
Hyperin
Rutin
3,5,
Que
Que
Que
flavanone
Liquiritigenin
Naringenin
Liquiritin
Naringin
7,4’
5,7,
Liqu
Nar
isoflavone
Daidzein 7,4’
Formononetin 7-H
Genistein 5,7,
Puerarin Dai
Daidzin Dai
Genistin Gen
flavan-3-ol
(–)-Catechin
a“FA” and “FG” denote, respectively, flavonoid aglycones and flavono
Table 2. Oligodeoxynucleotides used in this study
Name Seq
Duplex 1 d(AACTCCCGGCACAC/GTG
Duplex 2 d(ACGCGGCGGGAGGA/TC
Duplex 3 d(GGCGAAATTTGCGG/CCG
Duplex 4 d(GGCGGAATTCGCGG/CCG
Duplex 5 d(GGCGGGATCCGCGG/CCGCCCThe purpose of the present study is to evaluate the
binding of flavonoids to DNA duplexes for the first
time using ESI-MS. Five DNA sequences were involved
(Table 2): two critical Sp-1 binding sites in human
surviving promoter (duplexes 1 and 2) were selected as
in our previous study [5]; the other three sequences
with different GC and AT content (duplexes 3, 4, and
5) were also selected to further investigate possible
sequence selectivities of the flavonoids. Binding sto-
Nomenclature Mass Notea
hydroxyflavone
ihydroxyflavone
Tetrahydroxyflavone
-7-O-glucuronic acid
-8-C-glucoside
270
270
286
446
432
FA
FA
FA
FG
FG
’-Pentahydroxyflavone
n-3-O-rhamnoside
n-3-O-galactoside
n-3-O-rhamnosylglucoside
302
448
464
610
FA
FG
FG
FG
droxyflavanone
ihydroxyflavanone
enin-4’-O-glucoside
nin-7-O-rhamnosylglucoside
256
272
418
580
FA
FA
FG
FG
droxyisoflavone 254 FA
xy-4’-methoxyisoflavone 268 FA
ihydroxyisoflavone 270 FA
-8-C-glucoside 416 FG
-7-O-glucoside 416 FG
n-7-O-glucoside 432 FG
290 FA
cosides.
e Mass (Da)
CGGGAGTT) (ss1a/ss1b) 8524.5
CGCCGCGT) (ss2a/ss2b) 8526.5
TAAACGCC) (ss3a/ss3b) 8523.5
TAAGCGCC) (ss4a/ss4b) 8525.57-Tri
4’-Tr
3’,4’-
alein
genin
7,3’,4
rceti
rceti
rceti
-Dihy
4’-Tr
iritig
inge
-Dihy
ydro
4’-Tr
dzein
dzein
isteiuenc
TGC
CTCC
CTT
CCTTAGGCGCC) (ss5a/ss5b) 8527.5
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ion mass spectra. Relative binding affinities of the
flavonoids for the DNA duplexes were also evaluated
and structural features for their DNA-binding prop-
erties were elucidated. Finally, the stabilities of the
flavonoid/DNA complexes were examined using
collision-induced dissociation (CID) experiments.
The results demonstrate that ESI-MS is a powerful
tool for investigation of the interactions between
flavonoids and DNA.
Experimental
Materials
Milli-Q™ water (Millipore, Bradford, MA, USA) was used
in all the experiments. Methanol was of HPLC grade
from Fisher Chemicals (Fair Lawn, NJ, USA). All the
flavonoids (Table 1) were obtained from the National
Institute for the Control of Pharmaceutical and Biolog-
ical Products (Beijing, China). Stock solutions of the
flavonoids were prepared in methanol at a concentra-
tion of 1 mM.
Single-strand oligodeoxynucleotides (ODNs) were
purchased from Takara Biotechnology Co., Ltd. (Dalian,
China) and used without further purification. Stock solu-
tions of each ODN were prepared at 2 mM concentration
in Milli-Q water. Annealing was achieved by preparing
solutions containing two complementary ODN strands in
500 mM ammonium acetate. For duplexes 1, 3, 4, and 5,
equal volumes of each complementary ODN were mixed.
However, for duplex 2, the volume ratio of ss2a to ss2b
was adjusted to 2:1 to ensure that the duplex ion was
predominant in the spectrum. The annealing solutions
were heated to 90 °C for 15 min and slowly cooled at 4 °C
overnight to form the DNA duplexes. Concentrations of
the single strands were estimated by UV spectroscopic
measurements at 260 nm and the extinction coefficients
provided by the manufacturer.
For analysis, solutions containing one duplex and
one flavonoid with a 1:4 M ratio (20 and 80 M,
respectively, except for the concentration-dependent
study) were prepared in methanol/50 mM ammonium
acetate (1:3, vol/vol) and allowed to equilibrate at room
temperature.
Mass Spectrometry
All the mass spectra were collected on a Finnigan LCQ
ion trap mass spectrometer (ThermoFinnigan, San Jose,
CA, USA) in negative-ion mode. The sample solutions
were infused into the mass spectrometer via a Harvard
syringe pump (Holliston, MA, USA) at a flow rate of 3
L/min. The spray voltage was set to 3.0 kV. The
heated capillary temperature was set at 140 °C and
nitrogen sheath and auxiliary gas flows of 50 and 15
arbitrary units, respectively, were used to ensure effi-
cient desolvation. Other instrumental conditions wereautotuned using the free duplex ions. Spectra were
acquired by summing 30 scans.
CID experiments were performed on selected com-
plexes by isolating the desired precursor ion in the ion
trap, followed by fragmentation promoted with incre-
ment of the collision energy until the intensity of the
precursor ion was reduced to approximately 10–20% of
its original abundance. A default activation time of 30
ms was used during all the measurements.
Results and Discussion
Binding of Flavonoid Aglycones to DNA Duplexes
The interactions between flavonoid aglycones and
DNA duplexes have been extensively studied by sev-
eral solution-phase methods [20–25]. In this study,
complexation of the aglycones with the duplexes was
first evaluated by negative-ion ESI-MS to demonstrate
that results obtained by MS can be correlated to the
solution-binding behaviors.
Solutions containing one flavonoid aglycone and one
duplex at a 4:1 M ratio (80 and 20 M, respectively)
were analyzed using negative-ion ESI-MS, and repre-
sentative mass spectra are shown in Figure 1a–e.
Among these aglycones, quercetin and genistein have
long been recognized as efficient topoisomerase poisons
and their binding to DNA structures has been exten-
sively studied [20–24]. In the negative-ion mass spectra,
peaks corresponding to the 1:1 and 2:1 flavonoid/DNA
complexes were clearly observed for these two agly-
cones (Figure 1c and e). The same binding stoichiome-
tries were obtained for the other flavonoid aglycones
(except for baicalein and formononetin), with complex
ions above 5% relative intensities.
In contrast, for solutions containing the aglycone
baicalein or formononetin, peaks corresponding to
the flavonoid/DNA complexes were not detected (Fig-
ure 1a), indicating rather weak interactions between the
duplex and these two flavonoid aglycones. This obser-
vation was in agreement with previous results obtained
using fluorescence intercalator displacement (FID) assay
[18]. The absence of DNA complex ions with baicalein or
formononetin could also be used to preclude the forma-
tion of nonspecific aggregates between the flavonoids and
DNA duplexes in the gas phase under the present exper-
imental conditions.
The binding results of the aglycones with the other
four duplexes were similar to those obtained for the
duplex 1, suggesting that these aglycones do not have
significant sequence selectivities. Therefore, these re-
sults have demonstrated that ESI-MS is indeed an
effective method for screening the DNA-binding prop-
erties of the flavonoid ligands.
Binding of Flavonoid Glycosides to DNA Duplexes
In plants, various modified forms of flavonoid agly-
cones also exist and exert a wide range of biological
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nized as the most important modified form. Flavonoid
O-glycosides exist commonly with one or more hy-
droxyl groups of the aglycone linked with a sugar chain
to form a glycosidic OOC bond. In addition, glycosyl-
ation can also occur by direct linkage of the sugar chain
to the flavonoid’s basic nucleus via a COC bond,
forming flavonoid C-glycosides. The flavonoid glyco-
sides exhibit various biological activities including an-
ticancer, anti-HIV, and antiviral effects [8, 9]. In princi-
ple, any of the hydroxyl groups and basic nucleus in the
aglycones can be glycosylated; however, certain posi-
tions are favored: for example, the 7- and/or 4=-OH
group in flavones, flavanones, and isoflavones; the
3-OH group in flavonols; and the C-6 and/or C-8
position of the flavonoid nucleus [9]. Compared with
the flavonoid aglycones, binding interactions of fla-
vonoid glycosides with nucleic acid structures have
been investigated less frequently.
Solutions containing a 4:1 ratio (80 and 20 M, respec-
tively) of one flavonoid glycoside and one duplex were
also examined by negative-ion ESI-MS. All the fla-
vonoid glycosides studied were found to form com-
plexes with the DNA duplexes, exhibiting a variety of
binding stoichiometries as demonstrated in Figure 1f–j.
For the flavone glycuronide baicalin, only the complex
Figure 1. Representative ESI mass spectra of
flavonoid aglycones (a–e) and flavonoid glycosid
with .with 1:1 binding stoichiometry was observed (Figure1f). In the case of the flavonoid diglycosides rutin and
naringin, the 1:1 and 2:1 flavonoid/DNA complexes
could be observed (Figure 1h). For the remaining fla-
vonoid glycosides, the flavonoid/DNA complexes
showed binding stoichiometries ranging from 1:1 and
3:1. It is worth noting that, in the mass spectrum
obtained for the flavone glycoside vitexin (Figure 1g),
the 1:1 flavonoid/DNA complex was the most abun-
dant, whereas the abundance of 2:1 complex was nearly
equal to that of free duplex. However, for the other
flavonoid glycosides, the abundances of the complexes
were lower than that of the free duplex. These results
suggested that vitexin undergoes more extensive com-
plexation with the DNA duplex than the other fla-
vonoid glycosides, which may be attributed to the
specific structure of vitexin (see discussion in the next
section). Similar binding results were obtained for the
complexes of the other four DNA duplexes with these
flavonoid glycosides.
Relative Binding Affinities of the Flavonoids to
DNA Duplexes
The relative binding affinities of the flavonoids toward
tions containing a 1:4 ratio of duplex 1 with
–j). Ions from single-stranded DNA are markedsolu
es (fthe DNA duplexes were compared using the values of
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the following equation:
Fraction of bound DNA (I(1:1) I(1:2) I(1:3)
 · · · ) ⁄ (IDNA I(1:1) I(1:2) I(1:3) · · · )
where IDNA is the relative abundance of the free DNA
and I(1:n) represents the relative abundances of the
DNA/flavonoid complexes in the ESI mass spectra.
With an assumption that the ESI response factors of the
free DNA and the drug/DNA complexes are identical,
the relative intensities of the free and bound DNA in the
mass spectra are expected to be proportional to their
relative abundances in solution [34]. Therefore, the
values of fraction of bound DNA can be used as a
unique parameter to compare the relative binding af-
finities of drugs with DNA structures [41–43]. Higher
values of fraction of bound DNA indicate greater DNA-
binding affinities. It has also been demonstrated in
several studies that the relative binding affinities mea-
sured by ESI-MS were in fairly good agreement with
the results obtained using solution-phase techniques
[41–43]. Here, the relative binding affinities of the
flavonoids toward duplex 1 are shown in Figure 2 as an
example. The results for the other four duplexes fol-
lowed the same trend (data not shown).
It can be seen from Figure 2 that the 4=-OH group of
flavonoid aglycones is essential for their DNA-binding
properties. For example, both baicalein and apigenin
contain three OH groups, two of which are at the 5 and
7 positions of ring A. The only difference between these
two molecules is the position of the third OH group,
that is, baicalein has a 6-OH, whereas apigenin has a
4=-OH; this subtle difference resulted in a significant
Figure 2. Relative binding affinities of the flavonoids to duplex 1
based on ESI-MS measurements. Inset shows the relative binding
affinities of quercetin to the five duplexes. The molar ratio of
flavonoid to DNA was 4:1.increase in the fraction of bound DNA of apigenin.
Replacement of the OH group by the OCH3 group at the
4=-position in the pair daidzein/formononetin, how-
ever, led to a notable decrease in the fraction of bound
DNA. These results suggested that the 4=-OH is of
primary importance for significant DNA binding of the
flavonoid aglycones, just as revealed in previous stud-
ies [12, 17, 19]. This hydroxyl group may form a
hydrogen bond with the DNA structures and stabilize
the complexes [17].
Glycosylation on the flavonoid aglycones was
proved to be related to the flavonoids binding to the
DNA duplexes. For the flavonoids used in this study,
glycosylation on either ring A or ring B of the agly-
cones, regardless of the identity of the sugar chain,
could undoubtedly result in a significant increase of the
DNA-binding affinities. As seen in Figure 2, the fla-
vonoid glycosides with sugar chains conjugated on
either of these two rings show much higher fraction-
bound values than their aglycone counterparts. It is not
surprising that glycosylation on the 4=-OH group in
liquiritin can lead to increased DNA-binding affinity
over the aglycone liquiritigenin because the conjugated
glucose can provide the necessary stabilization instead
of the 4=-OH in liquiritigenin and further enhance the
interactions by forming extra hydrogen bonds with the
DNA duplexes. Compared with rings A and B, glyco-
sylation on ring C (the 3-OH group of flavonol) seems
to have a less pronounced effect on the DNA-binding
affinities. In our study, the flavonol glycoside querce-
trin possessed approximately the same binding affinity
as that of its aglycone quercetin; hyperin showed a
slightly increased affinity toward the duplex, whereas
rutin exhibited a slight decrease of binding affinity.
Because these three flavonoid glycosides have the same
flavonol aglycone and differ only in the glycoside
moieties, the fraction-bound value differences suggest
that the sugar chain can affect their DNA-binding
properties. As reported previously [17, 22], the intro-
duction of rutinose on the 3-position of quercetin could
cause steric hindrance, which may contribute to the
unusual decrease in the DNA-binding affinity of rutin.
In addition, a detailed comparison of the fraction-
bound values obtained for the isoflavone glycosides
daidazin and puerarin further confirmed that the gly-
cosylation sites can affect the DNA-binding affinity.
Taken together, the sugar chains conjugated on the
aglycones may experience different spatial orientations
as a result of their conjugation sites and/or their iden-
tities, and cause different changes to the DNA-binding
properties of flavonoid glycosides.
The skeleton of the aglycones also has an impact on
the flavonoids binding to the DNA duplexes. For exam-
ple, the flavanone naringenin shows a higher fraction-
bound value, followed by the flavone apigenin, and
their isoflavone counterpart genistein shows a relatively
lower fraction-bound value. The case was more remark-
able in the pair liquiritigenin/daidzein: the flavanone
liquiritigenin exhibits a much higher fraction-bound
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It is obviously seen that the flavone and flavanone show
enhanced binding toward the duplexes than the isofla-
vones. As reported previously, the conjugation of ring B
on the C3 position introduces nonplanarity to the
isoflavone skeleton, which causes steric hindrance and
reduces the isoflavones binding to the DNA duplexes
[23]. In contrast, the steric hindrance is greatly reduced
in the flavone and flavanone with ring B conjugated on
the C2 position. In addition, the double bond between
C2 and C3 of the flavone skeleton allows extended
conjugation among the three rings and forms an inte-
grated -conjugated plane that may facilitate its bind-
ing to DNA [17, 19, 46, 47]. In the case of flavanone, the
single bond between C2 and C3 of the skeleton allows
free rotation of ring B relative to the plane defined by
ring A and ring C [47, 48], which may result in more
favorable conformations for its interaction with DNA.
Besides the 4=-OH group, the other hydroxyl substi-
tutions on the flavonoid aglycone can also affect their
DNA-binding properties. For example, the presence of
the 3=-OH group proved to cause a remarkable increase
in the fraction of bound DNA as easily seen in the pair
apigenin/luteolin. For the pair luteolin/quercetin, the
exchange of a hydrogen atom by a hydroxyl group at
the 3-position also increased the fraction-bound value.
Similar to the 4=-OH group, these additional hydroxyl
substitutions may enhance the DNA-binding affinities
of the flavonoids through hydrogen bonds with the
DNA duplexes. In the case of isoflavone, the presence of
the 5-OH group proved to correlate with increased DNA-
binding affinities, as demonstrated in the pairs daidzein/
genistein and daidzin/genistin. This observation corre-
sponds well with the previous results [12, 16, 19], and it
has been suggested that the presence of 5-OH in
genistein (or genistin) facilitates the formation of a
strong intramolecular hydrogen bond with the 4-keto
group and adds a six-membered ring moiety to the
structure, which may further promote the interactions
between the isoflavones and DNA [23]. Then, the rela-
tively weak DNA-binding affinity of daidzein com-
pared with those of the other aglycones with the 4=-OH
group may be a result of the steric hindrance of the
isoflavone skeleton (as discussed earlier) and the lack of
the 5-OH group.
Among the flavonoids studied, vitexin shows the
greatest relative DNA-binding affinity. The notable
structural features that may contribute to its exten-
sive complexation with DNA include the presence of
the important 4=-OH group, the planar flavone skeleton,
and the conjugated glucose on C8 of ring A, which may
be spatially well oriented to provide the most hydrogen
bonding and van der Waals interactions with the DNA
structures. The flavone glycoside baicalin shows the
lowest fraction of bound DNA, which may be largely
attributed to the lack of the important 4=-OH group. In
addition, charge repulsion should also be considered in
this case. As the only flavonoid with a negatively
charged sugar chain, baicalin may experience coulom-bic repulsion with the anionic backbone of the DNA in
solution and the gas phase, and thus reduce its binding
to the duplexes.
The sequence selectivities of these flavonoids were
evaluated on the basis of the relative binding affinities
of each flavonoid toward the five duplexes with differ-
ent GC and AT content. For each flavonoid, the fraction
values of bound DNA obtained for the five duplexes
were approximately the same (see inset of Figure 2 for
an example), suggesting that these flavonoids exhibit
minimal sequence selectivity.
Concentration Effects
The effects of ligand concentrations on the DNA com-
plexation were also examined. Duplex 1 was selected as
one representative DNA duplex, given that minimal
sequence selectivities were observed for all these fla-
vonoids. The concentration-dependent binding studies
were undertaken using a series of solutions containing
a fixed DNA concentration of 20 M and a variable
flavonoid concentration of 20, 40, 80, or 120 M. As the
flavonoid/DNA molar ratios were increased from 1:1 to
6:1, the relative abundances of the flavonoid/DNA
complexes increased and higher binding stoichiome-
tries were observed (data not shown). For example,
when the quercetin/duplex ratio was 1:1, only the 1:1
complex was observed with low abundance. As the
quercetin/duplex ratio was increased, the abundance of
the 1:1 complex increased and the 2:1 quercetin/DNA
complex emerged. When the quercetin/duplex ratio
was increased to 6:1, the 3:1 quercetin/DNA complex
was observed. Similar results were obtained for the
other flavonoids. Generally, the total number of bound
drugs was found to be dependent on the overall drug/
DNA ratio. The concentration-dependent binding of
these flavonoids is similar to the results obtained for
ligands that have several equivalent binding sites like
some well-known intercalators [31, 32]. This might
indicate an intercalating or nonspecific binding of these
flavonoids to the duplexes.
ESI-MS/MS of the Flavonoid/DNA Complexes
Although full-scan ESI-MS is useful to evaluate the
binding stoichiometries, relative binding affinities, and
sequence selectivities of the ligands toward the DNA
duplexes, it can provide little insight into the binding
interactions between the ligands and DNA. Previous
studies have demonstrated that the binding modes
could be deduced from the fragmentation patterns of
the drug/DNA complexes via collision-induced disso-
ciation [5, 29, 39–44]. Here, ESI-MS/MS experiments
were undertaken to examine the fragmentation patterns
as well as the stabilities of the flavonoid/DNA com-
plexes. The fragmentation patterns of the 5-charged
flavonoid/DNA complexes were systematically inves-
tigated because these fragmentation patterns have
proven more reflective of the drug/DNA interactions
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states in a quadrupole ion trap mass spectrometer [39].
For the 5-charged complexes containing flavonoid
aglycones, the predominant fragmentation pathway
was ejection of a neutral ligand, whereas the loss of a
nucleobase was insignificant or not observed. An exam-
ple of this characteristic fragmentation pattern is shown
in Figure 3a for the 1:1 complexes containing duplex 1
and quercetin. This fragmentation pattern is the same as
that obtained for the well-known anthrapyrazole inter-
calators [43], suggesting that these flavonoid aglycones
are likely to bind to the DNA duplexes via intercalation.
Moreover, the low abundances of product ions resulted
from base loss are indicative of weaker DNA-binding
affinities of the flavonoid aglycones than those conven-
tional intercalators previously studied [5, 29, 39]. The
intercalative binding mode and weak binding affinities
of the flavonoid aglycones toward DNA deduced from
the tandem mass spectrometry are in fairly good agree-
ments with the results obtained using solution-phase
techniques [20, 22, 24].
The fragmentation patterns of the 5-charged com-
plexes containing flavonoid glycosides are more com-
plicated than those for the flavonoid aglycones. Gener-
ally, the losses of a neutral ligand and nucleobase
occurred simultaneously. However, the extents of these
fragmentation pathways depend on the flavonoid gly-
coside studied. For the flavone glycoside vitexin, the
flavonol glycosides quercetrin, hyperin, rutin, and the
flavanone glycoside naringin, the complexes under-
went the predominant loss of nucleobase, whereas
ejection of a neutral ligand occurred to a lesser extent
(Figure 3b and d). In the case of the flavanone glycoside
liquiritin and the isoflavone glycosides puerarin, daid-
zin, and genistin, loss of a neutral ligand was the major
fragmentation pathway, whereas base loss occurred to a
lesser extent (Figure 3c). Unfortunately, a tandem mass
spectrum of the complex with the flavone glucuronide
baicalin was not obtained because of insufficient ion
abundances. It should be noted that, for complexes
containing the flavonol diglycoside rutin, loss of an
anion ligand was also observed via collision-induced
dissociation (Figure 3d); presumably, the 4-charged
Figure 3. Negative ion ESI-MS/MS spectra o
quercetin; (b) vitexin; (c) genistin; and (d) rutin. Precduplex is also formed; however, the m/z of this ion lies
out of the detectable mass range of the instrument.
The increased losses of nucleobase from the com-
plexes with flavonoid glycosides in the tandem mass
spectra suggest a different DNA-binding mode or
stronger DNA-binding interactions of these flavonoid
glycosides compared to that of their aglycone counter-
parts. Then, the relative DNA-binding affinities of the
flavonoids were taken into account. For the flavone,
flavanone, and isoflavone glycosides, the increased
nucleobase losses seem to correlate well with their
increased DNA-binding affinity. In this context, stron-
ger binding interactions of these flavonoid glycosides
toward the duplexes than their aglycone counterparts
are more likely. However, for complexes containing the
flavonol glycosides, the fragmentation patterns were
quite different from that obtained for their aglycone
counterpart quercetin, whereas the relative DNA-
binding affinities underwent less change. In this case,
the increased base losses in the tandem mass spectra are
more likely to be a result of distinct DNA-binding
modes of these flavonol glycosides from that of their
aglycone counterparts.
Effect of Glycosylation on the Flavonoids Binding
to DNA Duplexes
To further explore the effect of glycosylation on the
flavonoids binding to DNA duplexes, the mixture con-
taining a 4:1 M ratio (80 and 20 M, respectively) of
glucose and duplex 1 was prepared and examined
using negative-ion ESI-MS. No complex ions were ob-
served in the mass spectrum (data not shown). More-
over, mass spectra obtained from solutions containing a
1:4:4 M ratio of DNA duplex, flavonoid aglycone, and
glucose were almost identical to those obtained with-
out glucose. These results suggested that the binding of
glucose to the duplex was rather weak, which was
inconsistent with the previous results [49]. Therefore, it
is reasonable to assume that the enhanced binding of
flavone, flavanone, and isoflavone glycosides over their
aglycone counterparts did not result from simple addi-
5-charged 1:1 complexes of duplex 1 with (a)f the
ursor ions are labeled with an asterisk.
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The entity of the molecules with sugar chain covalently
linked onto the aglycones was necessary for the en-
hanced binding toward the DNA duplexes. Although
the exact binding site and the mode of interaction
between these flavonoid glycosides and DNA have not
yet been resolved, we assume that the sugar parts of
these flavone, flavanone, and isoflavone glycosides are
attached to some parts of the DNA molecule and lead to
enhanced binding affinities. Based on the previous
studies of the interactions between sugar-containing
drugs and DNA [50–53], the sugar chain in these
flavonoid glycosides may interact with the minor
grooves or form hydrogen bonds through the sugar OH
groups with the backbone phosphate units, and then
cause enhanced binding toward the DNA duplexes.
In the case of flavonols, glycosylation on the 3-OH
group did not result in significant changes of the
DNA-binding affinities, indicating that the additional
sugar chains engaged in DNA binding to a lesser extent
or the binding mode might be altered because of the
addition of sugar chain. Since the fragmentation pat-
terns of complexes with these flavonol glycosides were
quite different from those obtained for their aglycone
counterpart, it is more favorable that the sugar chains
conjugated on the 3-OH group result in a large alter-
ation of the DNA-binding mode.
Conclusion
This study demonstrates ESI-MS is a powerful tool to
evaluate noncovalent interactions between flavonoids
and DNA duplexes. Binding stoichiometries, relative
binding affinities, and sequence selectivities of the
flavonoids toward the DNA duplexes can be rapidly
estimated using negative-ion ESI-MS, and tandem mass
spectrometry may provide useful information on the
ligand-binding interactions. Our results have indicated
that the 4=-OH groups of flavonoid aglycones were of
primary importance for their DNA-binding properties
and that flavonoid glycosides with sugar chain linked
on ring A or ring B exhibited enhanced binding toward
the duplexes over their aglycone counterparts. The
aglycone skeleton as well as the other hydroxyl groups
on the aglycone also exert an impact on the flavonoids
binding to the duplexes. These results are expected to
provide a deeper insight into the DNA-binding prop-
erties of flavonoids and useful guidelines for design of
efficient anticancer agents.
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